Michael R. Wood

3.9k citations

79 papers · 2.4k indexed · h-index 28

Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research 25
- Neuropeptides and Animal Physiology 13
Organic Chemistry top 2%
Molecular Biology top 5%
- Receptor Mechanisms and Signaling 38
- Chemical Synthesis and Analysis 17
- Pharmacological Receptor Mechanisms and Effects 13
- Nicotinic Acetylcholine Receptors Study 8
Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 5
Biological Psychiatry top 10%
Psychiatry and Mental health
- Migraine and Headache Studies 4

Co-authors: Craig W. Lindsley P. Jeffrey Conn Bruce H. Lipshutz Colleen M. Niswender David A. Evans Timothy I. Richardson B. Wesley Trotter Jeffrey L. Katz
Cited by: Cellular and Molecular Neuroscience Organic Chemistry Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (3 papers)Angewandte Chemie International Edition (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Michael R. Wood

75 papers receiving 2.3k citations

Peers

Countries citing papers authored by Michael R. Wood

Since Specialization

Citations

This map shows the geographic impact of Michael R. Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Wood more than expected).

Fields of papers citing papers by Michael R. Wood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Wood. The network helps show where Michael R. Wood may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael R. Wood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael R. Wood Line = papers co-authored together Michael R. Wood links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate Nature Communications ·Jack Bibby,Harriet A. Purvis,Thomas S. Hayday,Anita Chandra,Klaus Okkenhaug,Sofia Rosenzweig,Ivona Aksentijevich,Michael R. Wood,Helen J. Lachmann,Claudia Kemper,Andrew P. Cope,Esperanza Perucha	2020	65
2	Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides Bioorganic & Medicinal Chemistry Letters ·James C. Tarr,Michael R. Wood,Meredith J. Noetzel,Jeanette L. Bertron,Rebecca L. Weiner,Alice L. Rodriguez,Atin Lamsal,Frank W. Byers,Sichen Chang,Hyekyung P. Cho,Carrie K. Jones,Colleen M. Niswender,Michael W. Wood,Nicholas J. Brandon,Mark E. Duggan,P. Jeffrey Conn,Thomas M. Bridges,Craig W. Lindsley	2017	16
3	Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition Bioorganic & Medicinal Chemistry Letters ·Michael R. Wood,Meredith J. Noetzel,James C. Tarr,Alice L. Rodriguez,Atin Lamsal,Sichen Chang,Jarrett J. Foster,Emery Smith,Peter Chase,Peter Hodder,Darren W. Engers,Colleen M. Niswender,Nicholas J. Brandon,Michael W. Wood,Mark E. Duggan,P. Jeffrey Conn,Thomas M. Bridges,Craig W. Lindsley	2016	7
4	Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4) SLAS DISCOVERY ·Emery Smith,Peter Chase,Colleen M. Niswender,Thomas J. Utley,Douglas J. Sheffler,Meredith J. Noetzel,Atin Lamsal,Michael R. Wood,P. Jeffrey Conn,Craig W. Lindsley,Franck Madoux,Mary Acosta,Louis Scampavia,Timothy Spicer,Peter Hodder	2015	25
5	Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model Neuropsychopharmacology ·Ayan Ghoshal,Jerri M. Rook,Jonathan W. Dickerson,G N Roop,Ryan D. Morrison,Nidhi Jalan‐Sakrikar,Atin Lamsal,Meredith J. Noetzel,Michael S. Poslusney,Michael R. Wood,Bruce J. Melancon,Shaun R. Stauffer,Zixiu Xiang,J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn	2015	81
6	State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 – Relation to antipsychotic-like drug effects Neuropharmacology ·Robert W. Gould,Michael T. Nedelcovych,Xuewen Gong,Erica Tsai,Michael Bubser,Thomas M. Bridges,Michael R. Wood,Mark E. Duggan,Nicholas J. Brandon,John Dunlop,Michael W. Wood,Magnus Ivarsson,Meredith J. Noetzel,J. Scott Daniels,Colleen M. Niswender,Craig W. Lindsley,P. Jeffrey Conn,Carrie K. Jones	2015	26
7	Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M₅‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe ChemMedChem ·Patrick R. Gentry,Masaya Kokubo,Thomas M. Bridges,Hyekyung P. Cho,Emery Smith,Peter Chase,Peter Hodder,Thomas J. Utley,Anuruddha Rajapakse,Frank W. Byers,Colleen M. Niswender,Ryan D. Morrison,J. Scott Daniels,Michael R. Wood,P. Jeffrey Conn,Craig W. Lindsley	2014	21
8	Influence of M ₁ muscarinic acetylcholine receptor activation on arousal and cognitive performance using electroencephalography and novel touchscreen cognition assessment (845.5) The FASEB Journal ·Robert W. Gould,Michael T. Nedelcovych,Ditte Dencker,Bruce J. Melancon,Shaun R. Stauffer,Michael R. Wood,Jürgen Wess,Zixiu Xiang,Craig W. Lindsley,P. Jeffrey Conn,Carrie K. Jones	2014	1
9	Discovery of ML326: The first sub-micromolar, selective M5 PAM Bioorganic & Medicinal Chemistry Letters ·Patrick R. Gentry,Thomas M. Bridges,Atin Lamsal,Paige N. Vinson,Emery Smith,Peter Chase,Peter Hodder,Julie L. Engers,Colleen M. Niswender,J. Scott Daniels,P. Jeffrey Conn,Michael R. Wood,Craig W. Lindsley	2013	20
10	Discovery of the First M₅-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375) Journal of Medicinal Chemistry ·Patrick R. Gentry,Masaya Kokubo,Thomas M. Bridges,Nathan R. Kett,Joel M. Harp,Hyekyung P. Cho,Emery Smith,Peter Chase,Peter Hodder,Colleen M. Niswender,J. Scott Daniels,P. Jeffrey Conn,Michael R. Wood,Craig W. Lindsley	2013	56
11	Isatin replacements applied to the highly selective, muscarinic M1 PAM ML137: Continued optimization of an MLPCN probe molecule Bioorganic & Medicinal Chemistry Letters ·Bruce J. Melancon,Michael S. Poslusney,Patrick R. Gentry,James C. Tarr,Douglas J. Sheffler,Margrith E. Mattmann,Thomas M. Bridges,Thomas J. Utley,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Michael R. Wood	2012	17
12	Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor Bioorganic & Medicinal Chemistry Letters ·Bruce J. Melancon,Rocco D. Gogliotti,James C. Tarr,Sam A. Saleh,Brian A. Chauder,Evan P. Lebois,Hyekyung P. Cho,Thomas J. Utley,Douglas J. Sheffler,Thomas M. Bridges,Ryan D. Morrison,J. Scott Daniels,Colleen M. Niswender,P. Jeffrey Conn,Craig W. Lindsley,Michael R. Wood	2012	14
13	Development of a more highly selective M1 antagonist from the continued optimization of the MLPCN Probe ML012 Bioorganic & Medicinal Chemistry Letters ·Bruce J. Melancon,Alexander P. Lamers,Thomas M. Bridges,Gary A. Sulikowski,Thomas J. Utley,Douglas J. Sheffler,Meredith J. Noetzel,Ryan D. Morrison,J. Scott Daniels,Colleen M. Niswender,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley,Michael R. Wood	2011	6
14	Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery Journal of Medicinal Chemistry ·Bruce J. Melancon,Corey R. Hopkins,Michael R. Wood,Kyle A. Emmitte,Colleen M. Niswender,Arthur Christopoulos,P. Jeffrey Conn,Craig W. Lindsley	2011	188
15	Muscarinic Receptor Pharmacology and Circuitry for the Modulation of Cognition Handbook of experimental pharmacology ·Michael Bubser,Nellie Byun,Michael R. Wood,Carrie K. Jones	2011	99
16	The antipsychotic potential of muscarinic allosteric modulation Drug News & Perspectives ·Thomas M. Bridges,Evan P. Lebois,Corey R. Hopkins,Michael R. Wood,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley	2010	50
17	5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,Christina N. Di Marco,Ronald K. Chang,Michael R. Wood,June J. Kim,Kathy M. Schirripa,Kathy Murphy,Richard W. Ransom,Cuyue Tang,Maricel Torrent,Sookhee Ha,Thomayant Prueksaritanont,Douglas J. Pettibone,Mark G. Bock	2006	10
18	Total Syntheses of Vancomycin and Eremomycin Aglycons Angewandte Chemie International Edition ·David A. Evans,Michael R. Wood,B. Wesley Trotter,Timothy I. Richardson,James C. Barrow,Jeffrey L. Katz	1998	214
19	Nonconventional Stereochemical Issues in the Design of the Synthesis of the Vancomycin Antibiotics: Challenges Imposed by Axial and Nonplanar Chiral Elements in the Heptapeptide Aglycons Angewandte Chemie International Edition ·David A. Evans,Christopher J. Dinsmore,Paul S. Watson,Michael R. Wood,Timothy I. Richardson,B. Wesley Trotter,Jeffrey L. Katz	1998	139
20	The value of revision surgery after initial amputation of an upper or lower limb Prosthetics and Orthotics International ·Michael R. Wood,Gordon A. Hunter,S. G. Millstein	1987	13

About Michael R. Wood

Michael R. Wood is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Process Chemistry and Technology, having authored 79 papers that have together received 2.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (38 papers), Neuroscience and Neuropharmacology Research (25 papers), Chemical Synthesis and Analysis (17 papers), Pharmacological Receptor Mechanisms and Effects (13 papers), Neuropeptides and Animal Physiology (13 papers), Nicotinic Acetylcholine Receptors Study (8 papers), Microbial Natural Products and Biosynthesis (5 papers) and Migraine and Headache Studies (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (850 citations), Organic Chemistry (797 citations) and Molecular Biology (1.4k citations). Michael R. Wood has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Craig W. Lindsley, P. Jeffrey Conn, Bruce H. Lipshutz, Colleen M. Niswender, David A. Evans, Timothy I. Richardson, B. Wesley Trotter, Jeffrey L. Katz, Bruce J. Melancon and Corey R. Hopkins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact